Variations in Oncologist Recommendations for Chemotherapy for Stage IV Lung Cancer: What Is the Role of Performance Status?
AUTHORS
Tisnado
D ,
Malin
J ,
Kahn
K ,
Landrum
MB ,
Fletcher
R ,
Klabunde
C ,
Clauser
S ,
Rogers
SO ,
Keating
NL ,
. Journal of oncology practice / American Society of Clinical Oncology. 2016 7 1; 12(7). 653-62
- PMID: 27271507 [PubMed].
- PMCID: PMC4957251.
ABSTRACT
Chemotherapy prolongs survival in patients with advanced non-small-cell lung cancer. However, few studies have included patients with poor performance status. This study examined rates of oncologists’ recommendations for chemotherapy by patient performance status and symptoms and how physician characteristics influence chemotherapy recommendations.
Chemotherapy prolongs survival in patients with advanced non-small-cell lung cancer. However, few studies have included patients with poor performance status. This study examined rates of oncologists’ recommendations for chemotherapy by patient performance status and symptoms and how physician characteristics influence chemotherapy recommendations.
Tags: Alumni Publications 2016